TCA counsels Tecnovax on first issue of Notes
Tanoira Cassagne Abogados has counselled Tecnovax in its entry into the public offering regime and the creation of the global programme for the issuance of notes for up to a maximum amount of US$19,000,000 (or its equivalent in other currencies and/or units of value).
The operation also included the issuance of: the Series I Class 1 Green Notes, in pesos, maturing on January 13, 2025, for a total amount of $647,500,000, issued at a variable rate composed of the Private BADLAR rate plus a 5% bid cut-off margin; and the Series I Class 2 Green Notes, in US dollars and payable in pesos, maturing on July 13, 2026, for a total amount of US$ 3,094,444, at a fixed rate of 0.00%.
The Notes were issued on 13 July, in line with the four main components of the International Capital Market Association’s Green Bond principles, and in accordance with the “Guidelines for the Issuance of Social, Green and Sustainable Marketable Securities in Argentina” and as set out in the Social, Green and Sustainable Bond Guidelines of the Argentinean Stock Exchanges and Markets Panel (ByMA).
StoneX Securities acted as arranger and underwriter, also with advice from the firm.
Tecnovax is a biotechnology company dedicated to the research, development, production and commercialisation of vaccines and immunotherapies for animal health.
TCA’s team consisted of partners Alexia Rosenthal (pictured left) and Jaime Uranga (pictured right) and associates Lucía Viboud Aramendi, Juan Manuel Simó and Federico Grieben.
